Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Halder, Andreas
ENABLE-Hip, NCT06611319: ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty	Recruiting	3	2932	Europe	Prevention of Venous Thromboembolism, Rivaroxaban, Xarelto, anticoag, Direct oral anticoagulant, DOAC, Placebo Oral Tablet	Prof. Stavros Konstantinides, MD	Hip Arthroplasty, Total, Prevention of Venous Thromboembolism	03/27	07/27
Krieger, Manfred
ENABLE-Hip, NCT06611319: ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty	Recruiting	3	2932	Europe	Prevention of Venous Thromboembolism, Rivaroxaban, Xarelto, anticoag, Direct oral anticoagulant, DOAC, Placebo Oral Tablet	Prof. Stavros Konstantinides, MD	Hip Arthroplasty, Total, Prevention of Venous Thromboembolism	03/27	07/27